INM (InMed Pharmaceuticals Inc. Common Shares) Stock Analysis - Analyst Ratings
InMed Pharmaceuticals Inc. Common Shares (INM) is a publicly traded Healthcare sector company. As of May 19, 2026, INM trades at $1.46 with a market cap of $2.12M and a P/E ratio of -0.08. INM moved +133.58% today. Year to date, INM is -39.22%; over the trailing twelve months it is -76.93%. Its 52-week range spans $0.58 to $8.27. Rallies surfaces INM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What do analysts rate INM?
The average price target is $0.00.
INM Key Metrics
Key financial metrics for INM
Metric
Value
Price
$1.46
Market Cap
$2.12M
P/E Ratio
-0.08
EPS
$-8.36
Dividend Yield
0.00%
52-Week High
$8.27
52-Week Low
$0.58
Volume
64.89M
Avg Volume
0
Revenue (TTM)
$4.94M
Net Income
$-8.16M
Gross Margin
34.53%
INM Analyst Consensus
INM analyst coverage data. Average price target: $0.00.